Scott McComb Johnson
Managing Director @ PROOF
Cambridge, United States
Scott McComb Johnson is a Series A investor at PROOF in Cambridge focused on Advertising and Publishing. Scott Johnson is a managing partner at Venture Economics as one of the top performing post-IPO funds of 1999, where he oversaw investments in E.piphany, Silknet, Digital Think, and WebLogic. Before that, he co-founded InterSense, Inc., a VR tracking company. Scott began his career as a software engineer and early employee of Cambridge Technology Partners, a global systems integration and consulting company. He received his BS in operations research from Cornell University and his MBA from MIT's Sloan School of Management.
- Total investments:
- 21
- Last investment:
- Lead investor:
- 19%
Last updated:
For AI agents: llms.txt
Industries Scott McComb Johnson invests in
Stages Scott McComb Johnson invests in
Countries Scott McComb Johnson invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Advertising 4 (19%)
- Publishing 3 (14%)
- Analytics 2 (10%)
- Health Care 2 (10%)
- Digital Media 2 (10%)
Stage
- Series A 7 (33%)
- Series B 5 (24%)
- Seed 2 (10%)
- Series C 2 (10%)
- Pre-Seed 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Cascade is an AI platform that helps engineering, architecture, and construction firms predict upcoming projects and automatically find, score, and write proposals for high‑fit contracts, so they can win more work with less manual effort. | $3.5M / Seed / Jul 21, 2026 | ||
| Global Goods Exchange (GGX) is an AI trading platform that provides transaction exchange tools for traders and market makers. | $1M / Oct 14, 2024 | ||
| Global Goods Exchange (GGX) is an AI trading platform that provides transaction exchange tools for traders and market makers. | $700K / Pre-Seed / May 03, 2024 | ||
| Zipdrug provides patients access to low-cost pharmacies who deliver prescriptions right to their homes. Its platform allocates medicare advantage patients to pharmacies that will drive adherence for the lowest cost. It was founded in 2015 and is based in New York City. | $10.8M / Venture - Series Unknown / Feb 15, 2019 | ||
| Zipdrug provides patients access to low-cost pharmacies who deliver prescriptions right to their homes. Its platform allocates medicare advantage patients to pharmacies that will drive adherence for the lowest cost. It was founded in 2015 and is based in New York City. | $2.6M / Seed / Nov 17, 2015 | ||
| Yieldbot is a true technology company aiming to do nothing short of revolutionize the way media value is created for consumers, brands and publishers. They strive to consistently outperform expectations creating a better, more relevant web with their technology. In so doing, they believe they will enable the media industry to realize its true valuefor all three of the constituents that make the web what it is, and what it will become. | $18M / Series B / Jun 05, 2014 | ||
| Yieldbot is a true technology company aiming to do nothing short of revolutionize the way media value is created for consumers, brands and publishers. They strive to consistently outperform expectations creating a better, more relevant web with their technology. In so doing, they believe they will enable the media industry to realize its true valuefor all three of the constituents that make the web what it is, and what it will become. | $5M / Series A / Jul 01, 2013 | ||
| FashionPlaytes is a provider of an information service used to serve girls. Its service offers the latest reviews and recommendations of fashion, bars, restaurants, and more, thus enabling businesses to increase their reach. | $5M / Series B / Sep 11, 2012 | ||
| Truveris brings transparency to the prescription drug ecosystem through data-driven innovations. Truveris’ platform offers customers – from the individual patient to employers, retailers, pharmacy benefits stakeholders, and manufacturers – the data and insights they need to effectively and efficiently manage rising costs and market accesschallenges.Based in Manhattan, Truveris is backed by Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, New Atlantic Ventures and First Round Capital. | $10M / Series B / Feb 23, 2012 | ||
| Yieldbot is a true technology company aiming to do nothing short of revolutionize the way media value is created for consumers, brands and publishers. They strive to consistently outperform expectations creating a better, more relevant web with their technology. In so doing, they believe they will enable the media industry to realize its true valuefor all three of the constituents that make the web what it is, and what it will become. | $4.2M / Series A / Feb 22, 2012 | ||
| See all 21 investments → | |||
Co-Investors
About PROOF
PROOF utilizes an access strategy to partner with seed and early-stage funds, helping them exercise anti-dilution rights for their performing entities. It manages a co-investment platform that allows partners to increase their exposure to specific growth opportunities. The firm directs capital toward businesses in diverse technology and venture sectors that are transitioning into hypergrowth phases. Its investment model involves shared economics with venture partners who retain their board positions.
PROOF Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jennifer Schretter
General Partner
|
|||
Thanasis Delistathis
Co-Founder & Managing Partner
|
|||
John Backus
Co-Founder and Managing Partner
|
|||
John Burke
Co-Founder & Managing Partner
|
|||
|
Scott McComb Johnson
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Scott McComb Johnson invest in?
Scott McComb Johnson invests primarily in Advertising, Publishing and Analytics startups, most often at Series A and Series B stage. Most of the 21 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Scott McComb Johnson?
Public channels for Scott McComb Johnson include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Scott McComb Johnson last invest?
The most recent investment recorded for Scott McComb Johnson closed in Jul 2026. Shizune tracks 21 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
